Furthermore, Gab2 governs tumorigenic signaling and is a novel potential therapeutic target in leukemia, breast cancer, ovarian cancer, and melanoma (23); therefore, we hypothesized that Gab2 may be involved in hepatocellular carcinogenesis. Here, GAB2 is linked to breast cancer.